Last updated 2026-07-20
- Acquired by Nuwellis, Inc., Mar 2026
- Raised $14M Series B led by BlueRed Partners, Oct 2021
- Raised $10M Series A, Dec 2017
Total raised
$29.8M
Last: Undisclosed Round 2021-11
Stage
Acquired
Founded
2009
Headcount
9
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Rendiatech is an Israeli-based medical device company specializing in real-time urine flow and acute kidney injury (AKI) monitoring technologies. Their primary product, Clarity RMS, is an FDA-cleared critical care monitoring system that continuously measures urine flow and provides real-time data and alerts for fluctuations to medical staff. The company's technology aims to facilitate early detection of changes in renal function and AKI risk, as well as treatment monitoring, improving critical care management in ICU and perioperative settings. Rendiatech was formed to acquire certain assets of RenalSense Ltd. following its bankruptcy proceedings.
Funding history · 5 rounds · $29.8M total
2021-10
B Round
$14.0M
★ BlueRed Partners
2019-04
Grant
$828K
2017-12
A Round
$10.0M
2014-02
Seed
$4.0M
2010-12
Pre-Seed
$1.0M
Headcount over time
From 10 (2018-07) to 8 (2025-12) · -2 (-20%) · 40 points · source: Finder history + radar grounding
Q&A
- What is Rendiatech's primary business?
- Rendiatech is a medical device company focused on real-time renal diagnostics. Their main product, Clarity RMS, is a critical care monitoring system designed for early detection of changes in renal function and acute kidney injury (AKI) risk.
- When was Rendiatech acquired and by whom?
- Rendiatech was acquired by Nuwellis in August 2025.
- What is the status of Rendiatech's Clarity RMS product?
- The Clarity RMS system has received FDA clearance and CE certification. It is currently installed in operating rooms, ICUs, and transplant and COVID-19 units in medical centers across the U.S., Europe, and Israel.
- What was Rendiatech's most recent funding round?
- Rendiatech raised $14,000,000 in November 2021, with BlueRed Partners as a lead investor.
- How much total funding has Rendiatech raised?
- Rendiatech has raised a total of $29,828,000 across multiple funding rounds.
- How many employees does Rendiatech have?
- Rendiatech has 1-10 employees.
- Who are the co-founders of Rendiatech?
- Rendiatech was co-founded by Avi Kleiman, who serves as CEO, and Mor Grinstein, who is no longer with the company.
- What technologies does Rendiatech utilize?
- Rendiatech utilizes Artificial Intelligence, Machine Learning, and Sensing technologies in its products.
Team · 2
Avi Kleiman
Founder · Co-founder & CEO
Mor Grinstein
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Monitors
Technologies
Artificial IntelligenceMachine LearningSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2BB2B2C
Highlights
1 PatentsVerified
Tags
early-detectionsensorsnephrologymedical-devicesreal-timediagnosticspreventionmonitoringhospitalsmedical-technologiesnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/10424427 |
Identifiers & details
| Legal name | RENDIATECH LTD |
|---|---|
| Founded | 2009-6 |
| Employees (exact) | 9 |
| Offices | Brookline |
| Status reason | Acquired by Nuwellis on Aug, 2025 |
Acquisitions & public offerings
Acquired by Nuwellis, Inc. 2026-03
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517143046 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2025-03-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), shares_capital (1) |
| Registered address | המרפא 3 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-25 | עדכון בעלי תפקידים |
| 2025-09-02 | הקצאת מניות |